Samsung Biologics

207940.KO

907.03 USD

-46.95

-4.92%

Overview

Last close

907.03 usd

Market cap

42.23B usd

52 week high

1154.38 usd

52 week low

655.09 usd

Target price

746.13 usd

Valuation

P/E

N/A

Forward P/E

34.8432

Price/Sales

11.0811

Price/Book Value

7.5537

Enterprise Value

46.40B usd

EV/Revenue

12.1439

EV/EBITDA

20.7748

Key financials

Revenue TTM

3.82B usd

Gross Profit TTM

2.07B usd

EBITDA TTM

2.11B usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

8.18B usd

Net debt

437.33M usd

About

Samsung Biologics Co.,Ltd., together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally. Its development services include late discovery, cell line development, process development, analytical development, and non-GMP / CGMP manufacturing. The company also offers aseptic filling, lyophilization, finishing, cold chain storage and shipping, and regulatory support services; and quality services and analytical testing services, such as IPC and release testing, stability study and testing, environmental monitoring, biosafety testing, as well as manufactures drug substance. In addition, it engages in the development and manufacture of antibody-drug conjugates and mRNA products. The company was founded in 2011 and is headquartered in Incheon, South Korea.